PMEF
ONC

Point72 Middle East FZE’s BeOne Medicines Ltd ONC Stock Holding History

Point72 Middle East FZE’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-57
Closed -$10.3K – 1398
2023
Q4 		$10.3K Buy
+57
New +$10.3K ﹤0.01% 1397

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Point72 Middle East FZE's ONC Position: Q1 2024 in Review

Point72 Middle East FZE sold out of BeOne Medicines Ltd (ONC) in Q1 2024, closing a stake of 57 shares — an estimated $10.3K sold.

Point72 Middle East FZE first reported a position in ONC in Q4 2023 and held it in 1 quarter. The position peaked at $10.3K in Q4 2023. 204 funds tracked by Wall St. Rank hold ONC as of Q1 2024.

  • Point72 Middle East FZE reported no remaining BeOne Medicines Ltd position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 57 BeOne Medicines Ltd shares in Q1 2024, an estimated $10.3K.
  • Point72 Middle East FZE first reported a position in BeOne Medicines Ltd in Q4 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's BeOne Medicines Ltd position peaked at $10.3K in Q4 2023.
  • 204 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.